Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated versions of the virus circulating in that country and South Africa. The South African study included some volunteers with HIV.
https://news.yahoo.com/novavax-vaccine-seems-effective-against-213419457.html

